Chas Pulido

Chas Pulido

Fondateur chez Alix Ventures

Health Technology
Technology Services
Commercial Services

Profil

Chas Pulido is the founder of Alix Ventures, which was founded in 2019.
He is currently an investor at Clora LLC, Mythic Therapeutics, Inc., Arc Care, Inc., Xilis, Inc., Elegen Corp., 64-X, Inc., Endpoint Health, Inc., Basil Systems, Inc., Teiko Bio, Inc., and Zafrens, Inc. He is also an advisor and first investor at Getlabs, Inc. and an advisor at Membio, Inc. Mr. Pulido received his undergraduate degree from the University of Notre Dame.

Postes actifs de Chas Pulido

SociétésPosteDébut
Fondateur 01/01/2019
Private Equity Investor 01/01/2020
Private Equity Investor 01/01/2022
Private Equity Investor 01/01/2021
Private Equity Investor 01/01/2021
Private Equity Investor 01/01/2021
Private Equity Investor 01/01/2020
Consultant / Advisor 01/01/2019
Private Equity Investor 01/01/2021
░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Chas Pulido

Formation de Chas Pulido

University of Notre Dame Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chas Pulido

Relations

50

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées13

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Technology Services

Health Technology

Technology Services

Technology Services

Technology Services

Electronic Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Chas Pulido
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT